Krystal Biotech Inc
SWB:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
Shimano Inc
F:SHM1
|
JP |
|
Central Garden & Pet Co
NASDAQ:CENT
|
US |
|
Asahi Group Holdings Ltd
TSE:2502
|
JP |
|
N
|
Nutrien Ltd
LSE:0NHS
|
CA |
|
V
|
Verizon Communications Inc
XMUN:BAC
|
US |
|
P
|
Plug Power Inc
XETRA:PLUN
|
US |
|
Experian PLC
LSE:EXPN
|
IE |
|
B
|
Berkshire Hathaway Inc
LSE:0R37
|
US |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 342.15 EUR with a low forecast of 199.82 EUR and a high forecast of 457.99 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
342.15
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 342.15 EUR with a low forecast of 199.82 EUR and a high forecast of 457.99 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
